Quality of published studies supporting off-label and accelerated approval oncology indications

被引:0
|
作者
Carson, K. R.
Chia, Y.
Sekhar, J.
Coeytaux, R. R.
Wheeler, J. L.
Bennett, C. L.
Abernethy, A. P.
机构
[1] Washington Univ, St Louis, MO USA
[2] Barnes Jewish Hosp, St Louis, MO 63110 USA
[3] Duke Clin Res Inst, Durham, NC USA
[4] Duke Univ, Med Ctr, Duke Comprehens Canc Ctr, Durham, NC 27710 USA
[5] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA
[6] Duke Univ, Med Ctr, Durham, NC USA
关键词
D O I
10.1200/jco.2010.28.15_suppl.6059
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6059
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Off-label indications for medication use and the published literature
    Dresser, Rebecca
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (12): : 1411 - 1411
  • [2] Systematic Review: Reliability of Compendia Methods for Off-Label Oncology Indications
    Abernethy, Amy P.
    Raman, Gowri
    Balk, Ethan M.
    Hammond, Julia M.
    Orlando, Lori A.
    Wheeler, Jane L.
    Lau, Joseph
    McCrory, Douglas C.
    [J]. ANNALS OF INTERNAL MEDICINE, 2009, 150 (05) : 336 - +
  • [3] Off-label prescribing in oncology
    Poole, SG
    Dooley, MJ
    [J]. SUPPORTIVE CARE IN CANCER, 2004, 12 (05) : 302 - 305
  • [4] Off-label prescribing in oncology
    Susan G. Poole
    Michael J. Dooley
    [J]. Supportive Care in Cancer, 2004, 12 : 302 - 305
  • [5] Off-label indications for topical tacrolimus
    Hengge, U. R.
    [J]. HAUTARZT, 2013, 64 (10): : 752 - 756
  • [6] Biologics in dermatology: Off-label indications
    Mitra, Debdeep
    Chopra, Ajay
    Saraswat, Neerja
    Mitra, Barnali
    Talukdar, Krishna
    Agarwal, Reetu
    [J]. INDIAN DERMATOLOGY ONLINE JOURNAL, 2020, 11 (03) : 319 - 327
  • [8] Evaluating the Use of Dalbavancin for Off-Label Indications
    Taylor, Katherine
    Williamson, John
    Luther, Vera
    Stone, Tyler
    Johnson, James
    Gruss, Zachary
    Russ-Friedman, Courtney
    Ohl, Chris
    Beardsley, James
    [J]. INFECTIOUS DISEASE REPORTS, 2022, 14 (02) : 266 - 272
  • [9] Off-label indications for mifepristone in gynecology and obstetrics
    Dzuba, Ilana G.
    Grossman, Daniel
    Schreiber, Courtney A.
    [J]. CONTRACEPTION, 2015, 92 (03) : 203 - 205
  • [10] Off-label approval of drug use in a tertiary hospital
    Perez-Moreno, M. A.
    Villalba-Moreno, A. M.
    Santos-Ramos, B.
    Marin-Gil, R.
    Varela-Aguilar, J. M.
    Torello-Iserte, J.
    Nunez-Vazquez, R.
    Jimenez-Jimenez, J.
    Bautista-Paloma, F. J.
    [J]. REVISTA DE CALIDAD ASISTENCIAL, 2013, 28 (01) : 12 - 18